{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T21:03:32Z","timestamp":1784063012504,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374237"],"award-info":[{"award-number":["82374237"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"DOI":"10.1007\/s12011-026-05072-y","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T18:27:49Z","timestamp":1774636069000},"page":"5815-5829","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Realgar Transforming Solution as a Novel Arsenic Agent Triggers PINK1\/Parkin-Dependent Mitophagy and Apoptosis in the Molm-13 Acute Myeloid Leukemia Cell Line"],"prefix":"10.1007","volume":"204","author":[{"given":"Teng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyi","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"5072_CR1","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","volume":"401","author":"CD DiNardo","year":"2023","unstructured":"DiNardo CD, Erba HP, Freeman SD et al (2023) Acute myeloid leukaemia. Lancet 401:2073\u20132086. https:\/\/doi.org\/10.1016\/S0140-6736(23)00108-3","journal-title":"Lancet"},{"key":"5072_CR2","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/cncr.33458","volume":"127","author":"K Sasaki","year":"2021","unstructured":"Sasaki K, Ravandi F, Kadia TM et al (2021) De novo acute myeloid leukemia: A population-based study of outcome in the united states based on the surveillance, epidemiology, and end results (SEER) database, 1980 to 2017. Cancer 127:2049\u20132061. https:\/\/doi.org\/10.1002\/cncr.33458","journal-title":"Cancer"},{"key":"5072_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR et al (2022) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140:1345\u20131377. https:\/\/doi.org\/10.1182\/blood.2022016867","journal-title":"Blood"},{"key":"5072_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ccell.2019.06.003","volume":"36","author":"I Baccelli","year":"2019","unstructured":"Baccelli I, Gareau Y, Lehnertz B et al (2019) Mubritinib targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia. Cancer Cell 36:84\u201399e8. https:\/\/doi.org\/10.1016\/j.ccell.2019.06.003","journal-title":"Cancer Cell"},{"key":"5072_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41419-019-1851-3","volume":"10","author":"SB Panina","year":"2019","unstructured":"Panina SB, Baran N, Brasil da Costa FH et al (2019) A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugs. Cell Death Dis 10:617. https:\/\/doi.org\/10.1038\/s41419-019-1851-3","journal-title":"Cell Death Dis"},{"key":"5072_CR6","doi-asserted-by":"publisher","first-page":"1532857","DOI":"10.3389\/fonc.2024.1532857","volume":"14","author":"E Tjahjono","year":"2025","unstructured":"Tjahjono E, Daneman MR, Meika B et al (2025) Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia. Front Oncol 14:1532857. https:\/\/doi.org\/10.3389\/fonc.2024.1532857","journal-title":"Front Oncol"},{"key":"5072_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell AM, Youle RJ (2015) The roles of PINK1, parkin, and mitochondrial fidelity in parkinson\u2019s disease. Neuron 85:257\u2013273. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.007","journal-title":"Neuron"},{"key":"5072_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1369\/0022155415574818","volume":"63","author":"X-X Li","year":"2015","unstructured":"Li X-X, Tsoi B, Li Y-F et al (2015) Cardiolipin and its different properties in mitophagy and apoptosis. J Histochem Cytochem Off J Histochem Soc 63:301\u2013311. https:\/\/doi.org\/10.1369\/0022155415574818","journal-title":"J Histochem Cytochem Off J Histochem Soc"},{"key":"5072_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fnmol.2017.00120","volume":"10","author":"F Mouton-Liger","year":"2017","unstructured":"Mouton-Liger F, Jacoupy M, Corvol J-C et al (2017) PINK1\/parkin-dependent mitochondrial surveillance: From pleiotropy to parkinson\u2019s disease. Front Mol Neurosci 10:120. https:\/\/doi.org\/10.3389\/fnmol.2017.00120","journal-title":"Front Mol Neurosci"},{"key":"5072_CR10","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1080\/15548627.2023.2230839","volume":"19","author":"LM Meyer","year":"2023","unstructured":"Meyer LM, Koschade SE, Vischedyk JB et al (2023) Deciphering the mitophagy receptor network identifies a crucial role for OPTN (optineurin) in acute myeloid leukemia. Autophagy 19:2982\u20132996. https:\/\/doi.org\/10.1080\/15548627.2023.2230839","journal-title":"Autophagy"},{"key":"5072_CR11","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1038\/s41375-022-01614-0","volume":"36","author":"SB Panina","year":"2022","unstructured":"Panina SB, Pei J, Baran N et al (2022) Novel mitochondria-targeting compounds selectively kill human leukemia cells. Leukemia 36:2009\u20132021. https:\/\/doi.org\/10.1038\/s41375-022-01614-0","journal-title":"Leukemia"},{"key":"5072_CR12","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nchembio.1059","volume":"8","author":"RD Sentelle","year":"2012","unstructured":"Sentelle RD, Senkal CE, Jiang W et al (2012) Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy. Nat Chem Biol 8:831\u2013838. https:\/\/doi.org\/10.1038\/nchembio.1059","journal-title":"Nat Chem Biol"},{"key":"5072_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","volume":"72","author":"ME Huang","year":"1988","unstructured":"Huang ME, Ye YC, Chen SR et al (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567\u2013572","journal-title":"Blood"},{"key":"5072_CR14","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ctrv.2007.05.001","volume":"33","author":"PJ Dilda","year":"2007","unstructured":"Dilda PJ, Hogg PJ (2007) Arsenical-based cancer drugs. Cancer Treat Rev 33:542\u2013564. https:\/\/doi.org\/10.1016\/j.ctrv.2007.05.001","journal-title":"Cancer Treat Rev"},{"key":"5072_CR15","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/ajh.25271","volume":"93","author":"M-H Yang","year":"2018","unstructured":"Yang M-H, Wan W-Q, Luo J-S et al (2018) Multicenter randomized trial of arsenic trioxide and realgar-indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG-APL clinical study. Am J Hematol 93:1467\u20131473. https:\/\/doi.org\/10.1002\/ajh.25271","journal-title":"Am J Hematol"},{"key":"5072_CR16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3324\/haematol.2024.285905","volume":"110","author":"S Chen","year":"2025","unstructured":"Chen S, Qin W, Lu X et al (2025) Arsenic trioxide versus realgar-indigo naturalis formula in non-high-risk acute promyelocytic leukemia: A multicenter, randomized trial. Haematologica 110:621\u2013628. https:\/\/doi.org\/10.3324\/haematol.2024.285905","journal-title":"Haematologica"},{"key":"5072_CR17","doi-asserted-by":"publisher","first-page":"119339","DOI":"10.1016\/j.jep.2025.119339","volume":"341","author":"T Xue","year":"2025","unstructured":"Xue T, Tao Y, Wu Z et al (2025) Realgar induces apoptosis by inhibiting glycolysis via regulating STAT3 in myelodysplastic syndrome. J Ethnopharmacol 341:119339. https:\/\/doi.org\/10.1016\/j.jep.2025.119339","journal-title":"J Ethnopharmacol"},{"key":"5072_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2174\/0118722105284287240621053904","volume":"19","author":"W Ran","year":"2025","unstructured":"Ran W, Chen X, Grant J et al (2025) Critical review on the effect and mechanism of realgar nanoparticles on lymphoma: State of the art on in-vitro biomedical studies. Recent Pat Nanotechnol 19:581\u2013591. https:\/\/doi.org\/10.2174\/0118722105284287240621053904","journal-title":"Recent Pat Nanotechnol"},{"key":"5072_CR19","first-page":"991","volume":"23","author":"J-E Li","year":"2002","unstructured":"Li J-E, Wu W-L, Wang Z-Y et al (2002) Apoptotic effect of As2S2 on K562 cells and its mechanism. Acta Pharmacol Sin 23:991\u2013996","journal-title":"Acta Pharmacol Sin"},{"key":"5072_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1248\/bpb.b12-01015","volume":"36","author":"X Wang","year":"2013","unstructured":"Wang X, Zhang X, Xu Z et al (2013) Reversal effect of arsenic sensitivity in human leukemia cell line K562 and K562\/ADM using realgar transforming solution. Biol Pharm Bull 36:641\u2013648. https:\/\/doi.org\/10.1248\/bpb.b12-01015","journal-title":"Biol Pharm Bull"},{"key":"5072_CR21","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1016\/j.biortech.2010.11.059","volume":"102","author":"P Chen","year":"2011","unstructured":"Chen P, Yan L, Leng F et al (2011) Bioleaching of realgar by acidithiobacillus ferrooxidans using ferrous iron and elemental sulfur as the sole and mixed energy sources. Bioresour Technol 102:3260\u20133267. https:\/\/doi.org\/10.1016\/j.biortech.2010.11.059","journal-title":"Bioresour Technol"},{"key":"5072_CR22","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3892\/ijo.2016.3831","volume":"50","author":"P Song","year":"2017","unstructured":"Song P, Chen P, Wang D et al (2017) Realgar transforming solution displays anticancer potential against human hepatocellular carcinoma HepG2 cells by inducing ROS. Int J Oncol 50:660\u2013670. https:\/\/doi.org\/10.3892\/ijo.2016.3831","journal-title":"Int J Oncol"},{"key":"5072_CR23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s12272-019-01170-9","volume":"42","author":"Y Hai","year":"2019","unstructured":"Hai Y, Wang X, Song P et al (2019) Realgar transforming solution-induced differentiation of NB4 cell by the degradation of PML\/RAR\u03b1 partially through the ubiquitin\u2013proteasome pathway. Arch Pharm Res 42:684\u2013694. https:\/\/doi.org\/10.1007\/s12272-019-01170-9","journal-title":"Arch Pharm Res"},{"key":"5072_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jphs.2019.06.003","volume":"140","author":"Y Hai","year":"2019","unstructured":"Hai Y, Song P, Wang X et al (2019) Realgar transforming solution as a novel arsenic agent with a lower risk of cardiotoxicity. J Pharmacol Sci 140:162\u2013170. https:\/\/doi.org\/10.1016\/j.jphs.2019.06.003","journal-title":"J Pharmacol Sci"},{"key":"5072_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3109\/13880200903029381","volume":"48","author":"X Zhang","year":"2010","unstructured":"Zhang X, Xie Q-J, Wang X et al (2010) Biological extraction of realgar by acidithiobacillus ferrooxidans and its in vitro and in vivo antitumor activities. Pharm Biol 48:40\u201347. https:\/\/doi.org\/10.3109\/13880200903029381","journal-title":"Pharm Biol"},{"key":"5072_CR26","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1007\/s11033-024-09812-y","volume":"51","author":"S Yang","year":"2024","unstructured":"Yang S, Xu Y, Ahmad T et al (2024) Mdivi-1 alleviates ferroptosis induced by hypoxia combined with propofol in HT22 cells by inhibiting excessive mitophagy. Mol Biol Rep 51:870. https:\/\/doi.org\/10.1007\/s11033-024-09812-y","journal-title":"Mol Biol Rep"},{"key":"5072_CR27","doi-asserted-by":"publisher","first-page":"1586552","DOI":"10.3389\/fmed.2025.1586552","volume":"12","author":"M Li","year":"2025","unstructured":"Li M, Wang X, He W et al (2025) Drug-tolerant persister cells in acute myeloid leukemia: Pressing challenge and promising new strategies for treatment. Front Med 12:1586552. https:\/\/doi.org\/10.3389\/fmed.2025.1586552","journal-title":"Front Med"},{"key":"5072_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","volume":"16","author":"RS Bhansali","year":"2023","unstructured":"Bhansali RS, Pratz KW, Lai C (2023) Recent advances in targeted therapies in acute myeloid leukemia. J Hematol OncolJ Hematol Oncol 16:29. https:\/\/doi.org\/10.1186\/s13045-023-01424-6","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"5072_CR29","doi-asserted-by":"publisher","first-page":"7109","DOI":"10.18632\/aging.204281","volume":"14","author":"Z Li","year":"2022","unstructured":"Li Z, Zhang R, Yin X et al (2022) Realgar (As4S4), a traditional Chinese medicine, induces acute promyelocytic leukemia cell death via the bcl-2\/bax\/cyt-C\/AIF signaling pathway in vitro. Aging 14:7109\u20137125. https:\/\/doi.org\/10.18632\/aging.204281","journal-title":"Aging"},{"key":"5072_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40170-021-00253-w","volume":"9","author":"SB Panina","year":"2021","unstructured":"Panina SB, Pei J, Kirienko NV (2021) Mitochondrial metabolism as a target for acute myeloid leukemia treatment. Cancer Metab 9:17. https:\/\/doi.org\/10.1186\/s40170-021-00253-w","journal-title":"Cancer Metab"},{"key":"5072_CR31","doi-asserted-by":"publisher","first-page":"e6806","DOI":"10.1002\/cam4.6806","volume":"13","author":"C Fan","year":"2024","unstructured":"Fan C, Yang X, Yan L et al (2024) Oxidative stress is two-sided in the treatment of acute myeloid leukemia. Cancer Med 13:e6806. https:\/\/doi.org\/10.1002\/cam4.6806","journal-title":"Cancer Med"},{"key":"5072_CR32","doi-asserted-by":"publisher","first-page":"110064","DOI":"10.1016\/j.cbpc.2024.110064","volume":"288","author":"L Li","year":"2025","unstructured":"Li L, Li W, Liu Y et al (2025) MEHP induced mitochondrial damage by promoting ROS production in CIK cells, leading to apoptosis, autophagy, cell cycle arrest. Comp Biochem Physiol Part C Toxicol Pharmacol 288:110064. https:\/\/doi.org\/10.1016\/j.cbpc.2024.110064","journal-title":"Comp Biochem Physiol Part C Toxicol Pharmacol"},{"key":"5072_CR33","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1182\/blood-2014-08-594408","volume":"125","author":"S Sriskanthadevan","year":"2015","unstructured":"Sriskanthadevan S, Jeyaraju DV, Chung TE et al (2015) AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress. Blood 125:2120\u20132130. https:\/\/doi.org\/10.1182\/blood-2014-08-594408","journal-title":"Blood"},{"key":"5072_CR34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","volume":"8","author":"S Wang","year":"2023","unstructured":"Wang S, Long H, Hou L et al (2023) The mitophagy pathway and its implications in human diseases. Signal Transduct Target Ther 8:304. https:\/\/doi.org\/10.1038\/s41392-023-01503-7","journal-title":"Signal Transduct Target Ther"},{"key":"5072_CR35","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1182\/blood-2019-127024","volume":"134","author":"HRS Fay","year":"2019","unstructured":"Fay HRS, Dykstra KM, Johnson M et al (2019) Mitophagy plays a key role in the anti-leukemic activity of autophagy inhibitors under hypoxia in acute myeloid leukemia. Blood 134:1278. https:\/\/doi.org\/10.1182\/blood-2019-127024","journal-title":"Blood"},{"key":"5072_CR36","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1080\/15548627.2018.1558002","volume":"15","author":"R Rodrigo","year":"2019","unstructured":"Rodrigo R, Mendis N, Ibrahim M et al (2019) Knockdown of BNIP3L or SQSTM1 alters cellular response to mitochondria target drugs. Autophagy 15:900\u2013907. https:\/\/doi.org\/10.1080\/15548627.2018.1558002","journal-title":"Autophagy"},{"key":"5072_CR37","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/jnc.13412","volume":"136","author":"D Ivankovic","year":"2016","unstructured":"Ivankovic D, Chau K-Y, Schapira AHV et al (2016) Mitochondrial and lysosomal biogenesis are activated following PINK1\/parkin-mediated mitophagy. J Neurochem 136:388\u2013402. https:\/\/doi.org\/10.1111\/jnc.13412","journal-title":"J Neurochem"},{"key":"5072_CR38","doi-asserted-by":"publisher","first-page":"102355","DOI":"10.1016\/j.tranon.2025.102355","volume":"55","author":"J Xu","year":"2025","unstructured":"Xu J, Ren F, Wang J et al (2025) Tubeimoside I induces mitophagy by activating the PINK1\/parkin\/Mfn2 signaling pathway in acute myeloid leukemia cells. Transl Oncol 55:102355. https:\/\/doi.org\/10.1016\/j.tranon.2025.102355","journal-title":"Transl Oncol"},{"key":"5072_CR39","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1182\/blood-2016-04-708750","volume":"128","author":"M Dany","year":"2016","unstructured":"Dany M, Gencer S, Nganga R et al (2016) Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML. Blood 128:1944\u20131958. https:\/\/doi.org\/10.1182\/blood-2016-04-708750","journal-title":"Blood"},{"key":"5072_CR40","doi-asserted-by":"publisher","first-page":"1048177","DOI":"10.3389\/fcell.2023.1048177","volume":"11","author":"RA Zinovkin","year":"2023","unstructured":"Zinovkin RA, Lyamzaev KG, Chernyak BV (2023) Current perspectives of mitochondria-targeted antioxidants in cancer prevention and treatment. Front Cell Dev Biol 11:1048177. https:\/\/doi.org\/10.3389\/fcell.2023.1048177","journal-title":"Front Cell Dev Biol"},{"key":"5072_CR41","doi-asserted-by":"publisher","unstructured":"Mukem S, Thongbuakaew T, Khornchatri K Mito-tempo suppresses autophagic flux via the PI3K\/akt\/mTOR signaling pathway in neuroblastoma SH-SY5Y cells. Heliyon 2021;7. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07310","DOI":"10.1016\/j.heliyon.2021.e07310"},{"key":"5072_CR42","doi-asserted-by":"publisher","first-page":"1225578","DOI":"10.1155\/2022\/1225578","volume":"2022","author":"AJPO de Almeida","year":"2022","unstructured":"de Almeida AJPO, de Oliveira JCPL, da Silva Pontes LV et al (2022) Basic concepts, sources, cellular signaling, and its implications in aging pathways. Oxid Med Cell Longev 2022:1225578. https:\/\/doi.org\/10.1155\/2022\/1225578","journal-title":"Oxid Med Cell Longev"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-026-05072-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12011-026-05072-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-026-05072-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T20:03:36Z","timestamp":1784059416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12011-026-05072-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5072"],"URL":"https:\/\/doi.org\/10.1007\/s12011-026-05072-y","relation":{},"ISSN":["1559-0720"],"issn-type":[{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}